Influence of endogenous glucagon-like peptide-2 on lipid disorders in mice fed a high-fat diet

References

• Drucker DJ, Yusta B. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu Rev Physiol 2014;76:561–83.
   PubMed Web of Science ®Google Scholar
• Baldassano S, Amato A. GLP-2: what do we know? What are we going to discover? Regul Pep 2014;194: 6–10.
   Google Scholar
• Janssen P, Rotondo A, Mulé F, Tack J. A comparison of glucagon-like peptides 1 and 2. Aliment Pharmacol Ther 2013;37:18–36.
   PubMed Web of Science ®Google Scholar
• Jeppesen PB, Pertkiewicz M, Messing B, et al. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure. Gastroenterology 2012;143:1473–81.
   Google Scholar
• Baldassano S, Bellanca AL, Serio R, Mulè F. Food intake in lean and obese mice after peripheral administration of glucagon-like peptide 2. J Endocrinol 2012;213:277–84.
   PubMed Web of Science ®Google Scholar
• Tang-Christensen M, Larsen PJ, Thulesen J, et al. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 2000;6:802–07.
   PubMed Web of Science ®Google Scholar
• Amato A, Baldassano S, Serio R, Mule` F. Glucagon-like peptide-2 relaxes mouse stomach through vasoactive intestinal peptide release. Am J Physiol Gastrointest Liver Physiol 2009;296:G678–84.
   PubMed Web of Science ®Google Scholar
• Amato A, Rotondo A, Cinci L, et al. Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon. Am J Physiol Gastrointest Liver Physiol 2010;299:G1038–44.
   PubMedGoogle Scholar
• Rotondo A, Amato A, Baldassano S, et al. Gastric relaxation induced by glucagon-like peptide-2 in mice fed a high-fat diet or fasted. Peptides 2011;32:1587–92.
   PubMed Web of Science ®Google Scholar
• Baldassano S, Liu S, Qu MH, et al. Glucagon-like peptide-2 modulates neurally evoked mucosal chloride secretion in guinea pig small intestine in vitro. Am J Physiol Gastrointest Liver Physiol 2009;297:G800–05.
   Google Scholar
• Munroe DG, Gupta AK, Kooshesh P, et al. Prototypic G protein–coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci 1999;96:1569–73.
   PubMed Web of Science ®Google Scholar
• Angelone T, Filice E, Quintieri AM, et al. Receptor identification and physiological characterization of glucagon-like peptide-2 in the rat heart. Nutr Metab Cardiovasc Dis 2012;22:486–94.
   PubMed Web of Science ®Google Scholar
• El-Jamal N, Erdual E, Neunlist M, et al. Glucagon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration. Am J Physiol Gastrointest Liver Physiol 2014;307:G274–85.
   Google Scholar
• Cani PD, Possemiers S, Van de Wiele T, et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009;58:1091–1103.
   PubMed Web of Science ®Google Scholar
• Bahrami J, Longuet C, Baggio LL, et al. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse. Gastroenterology 2010;139:857–68.
   PubMed Web of Science ®Google Scholar
• Baldassano S, Amato A, Cappello F, et al. Glucagon-like peptide-2 and mouse intestinal adaptation to a high-fat diet. J Endocrinol 2013;217:11–20.
   PubMed Web of Science ®Google Scholar
• Baldassano S, Rappa F, Amato A, et al. GLP-2 involvement as a beneficial factor in the glucose homeostasis in mice fed a high fat diet. J Cell Physiol 2015;230:3029–36.
   PubMed Web of Science ®Google Scholar
• Hsieh J, Longuet C, Maida A, et al. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology 2009;137:997–1005.
   PubMed Web of Science ®Google Scholar
• Meier JJ, Nauck MA, Pott A, et al. Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology 2006;130:44–54.
   PubMed Web of Science ®Google Scholar
• Dash S, Xiao C, Morgantini C, et al. Glucagon-like peptide 2 regulates release of chylomicron from the intestine. Gastroenterology 2014;2:1–10.
   Google Scholar
• Hein GJ, Baker C, Hsieh J, et al. GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states. Diabetes 2013;62:373–81.
   PubMed Web of Science ®Google Scholar
• Jaiswal M, Schinske A, Pop-Busui R. Lipids and lipid management in diabetes. Best Pract Res Clin Endocrinol Metab 2014;28:325–38.
   PubMed Web of Science ®Google Scholar
• Nuzzo D, Picone P, Baldassano S, et al. Insulin resistance as common molecular denominator linking obesity to Alzheimer’s disease. Curr Alzheimer Res 2015;12:723–35.
   PubMed Web of Science ®Google Scholar
• Petit V, Arnould L, Martin P, et al. Chronic high-fat diet affects intestinal fat absorption and postprandial triglyceride levels in the mouse. J Lipid Res 2007;48:278–87.
   PubMed Web of Science ®Google Scholar
• Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497–509.
   PubMed Web of Science ®Google Scholar
• Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, et al. Mouse model of metabolic syndrome: insulin resistance, fatty liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr 2010;46:212–23.
   PubMed Web of Science ®Google Scholar
• de Meijer VE, Le HD, Meisel JA, et al. Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. Metabolism 2010;59:1092–1105.
   PubMed Web of Science ®Google Scholar
• Nishikawa S1, Sugimoto J, Okada M, et al. Gene expression in livers of BALB/C and C57BL/6J mice fed a high-fat diet. Toxicol Pathol 2012;40: 71–82.
   Google Scholar
• Nelson DW, Sharp JW, Brownfield MS, et al. Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat. Endocrinology 2007;148:1954–62.
   PubMed Web of Science ®Google Scholar
• Shin ED, Estall JL, Izzo A, et al. Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gastroenterology 2005;128:1340–53.
   PubMed Web of Science ®Google Scholar
• Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005;36:232–40.
   PubMed Web of Science ®Google Scholar
• Hsieh J, Hayashi AA, Webb J, Adeli K. Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity. Atheroscler Suppl 2008;9:7–13.
   PubMed Web of Science ®Google Scholar
• Abumrad NA, Davidson NO. Role of the gut in lipid homeostasis. Physiol Rev 2012;92:1061–85.
   PubMed Web of Science ®Google Scholar
• Dietschy JM, Turley SD, Spady DK. Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J Lipid Res 1993;34:1637–59.
   PubMed Web of Science ®Google Scholar
• Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol 2013;218:R25–36.
   PubMed Web of Science ®Google Scholar
• Cinci L, Faussone-Pellegrini MS, Rotondo A, et al. GLP-2 receptor expression in excitatory and inhibitory enteric neurons and its role in mouse duodenum contractility. Neurogastroenterol Motil 2011;23:e383–92.
   Google Scholar
• Guan X, Karpen HE, Stephens J, et al. GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 2006;130:150–64.
   PubMed Web of Science ®Google Scholar
• Brun P, Castagliuolo I, Di Leo V, et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007;292:G518–25.
   PubMed Web of Science ®Google Scholar
• Moore BA, Peffer N, Pirone A, et al. GLP-2 receptor agonism ameliorates inflammation and gastrointestinal stasis in murine postoperative ileus. J Pharmacol Exp Therap 2010;333:574–83.
   PubMed Web of Science ®Google Scholar